Sprecher C A, Morgenstern K A, Mathewes S, Dahlen J R, Schrader S K, Foster D C, Kisiel W
ZymoGenetics, Inc., Seattle, Washington 98102, USA.
J Biol Chem. 1995 Dec 15;270(50):29854-61. doi: 10.1074/jbc.270.50.29854.
A human placental lambda gt11 cDNA library was screened for sequences encoding proteins related to human proteinase inhibitor 6 (PI6), and two plaques were identified that displayed weak hybridization at high stringency. Isolation and characterization of the DNA inserts revealed two novel sequences encoding proteins composed of 376 and 374 amino acids with predicted molecular masses of approximately 42 kDa. The novel proteins displayed all of the structural features unique to the ovalbumin family of intracellular serpins including the apparent absence of a cleavable N-terminal signal sequence. The degree of amino acid sequence identity between the novel serpins and PI6 (63-68%) significantly exceeds that of any other combination of known intracellular serpins. The two novel serpins encoded by the two novel cDNA sequences have been designated as proteinase inhibitor 8 (PI8) and proteinase inhibitor 9 (PI9). The putative reactive center P1-P1' residues for PI8 and PI9 were identified as Arg339-Cys340 and Glu340-Cys341, respectively. PI9 appears to be unique in that it is the first human serpin identified with an acidic residue in the reactive center P1 position. In addition, the reactive center loop of PI9 exhibits 54% identity with residues found in the reactive center loop of the cowpox virus CrmA serpin. Two PI8 transcripts of 1.4 kilobases (kb) and 3.8 kb were detected by Northern analysis in equal and greatest abundance in liver and lung, while the 1.4-kb mRNA was in excess over the 3.8-kb mRNA in skeletal muscle and heart. Two PI9 transcripts of 3.4 and 4.4 kb were detected in equal and greatest abundance in lung and placenta and were weakly detected in all other tissues. PI8 and PI9 were expressed in baby hamster kidney and yeast cells, respectively. Immunoblot analyses using rabbit anti-PI6 IgG indicated the presence of PI8 in the cytosolic fraction of stably transfected cells that formed an SDS-stable 67-kDa complex with human thrombin. PI9 was purified to homogeneity from the yeast cell lysate by a combination of heparin-agarose chromatography and Mono Q fast protein liquid chromatography and migrated as a single band in SDS-polyacrylamide gel electrophoresis with an apparent molecular mass of 42 kDa. Purified recombinant PI9 failed to inhibit the amidolytic activities of trypsin, papain, thrombin, or Staphylococcus aureus endoproteinase Glu-C and did not form an SDS-stable complex when incubated with thrombin. The cognate intracellular proteinases that interact with PI8 and PI9 are unknown.
用人胎盘λgt11 cDNA文库筛选编码与人蛋白酶抑制剂6(PI6)相关蛋白质的序列,鉴定出两个在高严谨度下显示弱杂交的噬菌斑。对DNA插入片段进行分离和鉴定,发现了两个新序列,分别编码由376和374个氨基酸组成的蛋白质,预测分子量约为42 kDa。这些新蛋白质具有卵清蛋白家族细胞内丝氨酸蛋白酶抑制剂特有的所有结构特征,包括明显没有可裂解的N端信号序列。新丝氨酸蛋白酶抑制剂与PI6之间的氨基酸序列同一性程度(63 - 68%)显著超过任何其他已知细胞内丝氨酸蛋白酶抑制剂的组合。由这两个新cDNA序列编码的两种新丝氨酸蛋白酶抑制剂分别被命名为蛋白酶抑制剂8(PI8)和蛋白酶抑制剂9(PI9)。PI8和PI9的推定反应中心P1 - P1'残基分别被鉴定为Arg339 - Cys340和Glu340 - Cys341。PI9似乎很独特,因为它是第一个被鉴定出在反应中心P1位置有酸性残基的人丝氨酸蛋白酶抑制剂。此外,PI9的反应中心环与牛痘病毒CrmA丝氨酸蛋白酶抑制剂反应中心环中的残基具有54%的同一性。通过Northern分析在肝脏和肺中检测到1.4千碱基(kb)和3.8 kb的两种PI8转录本,其丰度相等且最高,而在骨骼肌和心脏中1.4 kb的mRNA比3.8 kb 的mRNA多。在肺和胎盘中检测到3.4和4.4 kb的两种PI9转录本,其丰度相等且最高,在所有其他组织中检测到的信号较弱。PI8和PI9分别在幼仓鼠肾细胞和酵母细胞中表达。使用兔抗PI6 IgG进行的免疫印迹分析表明,在稳定转染细胞的胞质部分存在PI8,它与人凝血酶形成了一种SDS稳定的67 kDa复合物。通过肝素 - 琼脂糖层析和Mono Q快速蛋白质液相层析相结合的方法,从酵母细胞裂解物中纯化得到了均一的PI9,其在SDS - 聚丙烯酰胺凝胶电泳中迁移为一条带,表观分子量为42 kDa。纯化的重组PI9不能抑制胰蛋白酶、木瓜蛋白酶、凝血酶或金黄色葡萄球菌内蛋白酶Glu - C的酰胺水解活性,并且与凝血酶孵育时不形成SDS稳定的复合物。与PI8和PI9相互作用的同源细胞内蛋白酶尚不清楚。